Back to search
Recurrent Tuberculosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent Tuberculosis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Recurrent Tuberculosis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a phase 2, double-blind, randomized (1:1), placebo-controlled trial with two parallel groups. * H56:IC31 (investigational vaccine) * Placebo 900 HIV…
Tuberculosis is a leading global cause of morbidity and mortality. Even if cured, a majority patients are left with bronchiectasis and fibrosis, permanent condi…